The risk of CHB progressing to HCC may be reduced by antiviral therapy [146], and surveillance with abdominal ultrasonography and serum alpha-fetoprotein tests can be used to screen patients for early HCC treatment. Here, AFP is linked to hepatocellular carcinoma.